Full Text Journal Articles by
Author Max J Coppes

Advertisement

Find full text journal articles






Surviving Survival-Challenge Accepted: Perspectives on Survivorship in Pediatric Oncology.

Max J Coppes, Leontine C M Kremer,

Pediatr Clin North Am (Pediatric clinics of North America)
[2020, 67(6):xix-xxi]

Cited: 0 times

View full text PDF listing >>



US direct-to-consumer medical service advertisements fail to provide adequate information on quality and cost of care.

Sung-Yeon Park, Gi Woong Yun, Sarah Friedman, Kylie Hill, So Young Ryu, Thomas L Schwenk, Max J Coppes,

<h4>Background</h4>In the 1970s, the Federal Trade Commission declared that allowing medical providers to advertise directly to consumers would be "providing the public with truthful information about the price, quality or other aspects of their service." However, our understanding of the advertising content is highly limited.<h4>Objective</h4>To assess whether direct-to-consumer medical service ... Read more >>

J Med Ethics (Journal of medical ethics)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Oral Health: A Critical Piece to Develop into a Healthy Adult.

Max J Coppes, Susan A Fisher-Owens,

Pediatr Clin North Am (Pediatric clinics of North America)
[2018, 65(5):xvii-xix]

Cited: 0 times

View full text PDF listing >>



PICU Outcomes: Does It Matter Whether the Children's Hospital Is Freestanding?

Anthony D Slonim, Max J Coppes,

Crit Care Med (Critical care medicine)
[2016, 44(12):2277-2278]

Cited: 0 times

View full text PDF listing >>



Outcome of patients with intracranial relapse enrolled on national Wilms Tumor Study Group clinical trials.

Rajkumar Venkatramani, Yueh-Yun Chi, Max J Coppes, Marcio Malogolowkin, John A Kalapurakal, Jing Tian, Jeffrey S Dome,

<h4>Background</h4>The occurrence of brain metastases (at diagnosis or at relapse) in patients with Wilms tumor is very rare.<h4>Methods</h4>We retrospectively reviewed the clinical characteristics of patients with Wilms tumor and relapse to the brain enrolled on the National Wilms Tumor Studies (NWTSs) 1-5.<h4>Results</h4>Intracranial relapse was documented in 47 patients (0.5%). Of ... Read more >>

Pediatr Blood Cancer (Pediatric blood & cancer)
[2017, 64(7):]

Cited: 0 times

View full text PDF listing >>



Neonatal and pediatric clinical pharmacology.

John N van den Anker, Max J Coppes, Gideon Koren,

Pediatr Clin North Am (Pediatric clinics of North America)
[2012, 59(5):xv-xviii]

Cited: 1 time

View full text PDF listing >>



Tribute: the American Society of Pediatric Hematology/Oncology (ASPHO) 2012 distinguished career award goes to Dr. Victor Blanchette.

Alvin Zipursky, Max J Coppes,

Pediatr Blood Cancer (Pediatric blood & cancer)
[2012, 58(7):1011-1013]

Cited: 1 time

View full text PDF listing >>



Safe pediatric care delivery.

Brian R Jacobs, Max J Coppes,

Pediatr Clin North Am (Pediatric clinics of North America)
[2012, 59(6):xv-xvii]

Cited: 1 time

View full text PDF listing >>



Preface: food allergy in children.

Hemant P Sharma, Robert A Wood, Max J Coppes,

Pediatr Clin North Am (Pediatric clinics of North America)
[2011, 58(2):xv-xvi]

Cited: 0 times

View full text PDF listing >>



Management of adults with Wilms' tumor: recommendations based on international consensus.

Heidi Segers, Marry M van den Heuvel-Eibrink, Kathy Pritchard-Jones, Max J Coppes, Michael Aitchison, Christophe Bergeron, Beatriz de Camargo, Jeffrey S Dome, Paul Grundy, Gemma Gatta, Norbert Graf, Paul Grundy, John A Kalapurakal, Jan de Kraker, Elizabeth J Perlman, Harald Reinhard, Filippo Spreafico, Gordan Vujanic, Anne B Warwick, ,

Since Wilms' tumor occurs rarely in adults, there are no standard treatments available. Most adult patients will be diagnosed unexpectedly following nephrectomy for presumed renal cell carcinoma. Outcome for adults is inferior compared with children, although better results are reported when treated within pediatric trials. Multiple factors, including the unfamiliarity ... Read more >>

Expert Rev Anticancer Ther (Expert review of anticancer therapy)
[2011, 11(7):1105-1113]

Cited: 7 times

View full text PDF listing >>



Candidate genes and potential targets for therapeutics in Wilms' tumour.

Christopher Blackmore, Max J Coppes, Aru Narendran,

Wilms' tumour (WT) is the most common malignant renal tumour of childhood. During the past two decades or so, molecular studies carried out on biopsy specimens and tumour-derived cell lines have identified a multitude of chromosomal and epigenetic alterations in WT. In addition, a significant amount of evidence has been ... Read more >>

Clin Transl Oncol (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico)
[2010, 12(9):597-605]

Cited: 1 time

View full text PDF listing >>



Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.

Robert C Shamberger, James R Anderson, Norman E Breslow, Elizabeth J Perlman, J Bruce Beckwith, Michael L Ritchey, Gerald M Haase, Milton Donaldson, Paul E Grundy, Robert Weetman, Max J Coppes, Marcio Malogolowkin, Patricia D Shearer, Morris Kletzel, Patrick R M Thomas, Roger Macklis, Vicki Huff, Douglas A Weeks, Daniel M Green,

<h4>Objective</h4>To determine the event-free survival (EFS) and overall survival (OS) of children with very low risk Wilms tumor (VLRWT) treated with surgery only.<h4>Background</h4>Previous studies suggested that postoperative chemotherapy had not improved the prognosis of children with VLRWT. A total of 77 children <24 months of age with small (<550 g) ... Read more >>

Ann Surg (Annals of surgery)
[2010, 251(3):555-558]

Cited: 34 times

View full text PDF listing >>



Preface. Developments in pediatric oncology and hematology.

Max J Coppes, Russell E Ware, Jeffrey S Dome,

Hematol Oncol Clin North Am (Hematology/oncology clinics of North America)
[2010, 24(1):xiii-xv]

Cited: 0 times

View full text PDF listing >>



Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis.

Ching Y Voss, Terry J Fry, Max J Coppes, Morris A Blajchman,

Most of the current cell-based immunotherapy protocols concentrate on immune stimulatory effects against certain pathogenic insults, such as cancer. In this article, a potential cell-based immunotherapeutic strategy to induce immune tolerance by infusion of apoptotic leukocytes is presented in conjunction with a review of newly understood mechanisms of action of ... Read more >>

Transfus Med Rev (Transfusion medicine reviews)
[2010, 24(1):22-32]

Cited: 14 times

View full text PDF listing >>



Routine bleeding history and laboratory tests in children presenting with a renal mass.

Victor Blanchette, Max J Coppes,

Pediatr Blood Cancer (Pediatric blood & cancer)
[2009, 52(3):314-315]

Cited: 0 times

View full text PDF listing >>



Pediatric hematology and pediatric oncology.

Max J Coppes, Russell E Ware,

Pediatr Clin North Am (Pediatric clinics of North America)
[2008, 55(2):xiii-xiv]

Cited: 0 times

View full text PDF listing >>



Rethinking pediatric assent: from requirement to ideal.

Yoram Unguru, Max J Coppes, Naynesh Kamani,

Physician-investigators are required to obtain informed consent from adult participants in their studies. Inclusion of children in research legally requires informed permission of a child's parent or guardian. It is increasingly recognized that a child need not assume a passive role when included in research, but that his or her ... Read more >>

Pediatr Clin North Am (Pediatric clinics of North America)
[2008, 55(1):211-22, xii]

Cited: 17 times

View full text PDF listing >>



Pediatric Clinics of North America: pediatric oncology. Preface.

Max J Coppes, Jeffrey S Dome,

Pediatr Clin North Am (Pediatric clinics of North America)
[2008, 55(1):xv-xvi]

Cited: 0 times

View full text PDF listing >>



Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.

Marcio Malogolowkin, Cecilia A Cotton, Daniel M Green, Norman E Breslow, Elizabeth Perlman, James Miser, Michael L Ritchey, Patrick R M Thomas, Paul E Grundy, Giulio J D'Angio, J Bruce Beckwith, Robert C Shamberger, Gerald M Haase, Milton Donaldson, Robert Weetman, Max J Coppes, Patricia Shearer, Peter Coccia, Morris Kletzel, Roger Macklis, Gail Tomlinson, Vicki Huff, Robert Newbury, Douglas Weeks, ,

<h4>Objective</h4>We evaluated the use of alternating cycles of cyclophosphamide/etoposide and carboplatin/etoposide in children entered on National Wilms Tumor Study (NWTS)-5 who were diagnosed between August 1, 1995 and May 31, 2002 and who relapsed after chemotherapy with vincristine, actinomycin D, and doxorubicin (VAD) and radiation therapy (DD-4A).<h4>Patients and methods</h4>One hundred ... Read more >>

Pediatr Blood Cancer (Pediatric blood & cancer)
[2008, 50(2):236-241]

Cited: 65 times

View full text PDF listing >>



Who will care for tomorrow's children with benign hematological conditions?

Max J Coppes, Laurence A Boxer,

Pediatr Blood Cancer (Pediatric blood & cancer)
[2007, 49(3):224]

Cited: 1 time

View full text PDF listing >>



Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.

Daniel M Green, Cecilia A Cotton, Marcio Malogolowkin, Norman E Breslow, Elizabeth Perlman, James Miser, Michael L Ritchey, Patrick R M Thomas, Paul E Grundy, Giulio J D'Angio, J Bruce Beckwith, Robert C Shamberger, Gerald M Haase, Milton Donaldson, Robert Weetman, Max J Coppes, Patricia Shearer, Peter Coccia, Morris Kletzel, Roger Macklis, Gail Tomlinson, Vicki Huff, Robert Newbury, Douglas Weeks,

<h4>Purpose</h4>NWTS-5 was a multi-institutional clinical trial for patients less than 16 years of age at diagnosis with specific renal neoplasms who were diagnosed between August 1, 1995 and May 31, 2002. A uniform approach to the treatment of patients with relapse was employed.<h4>Patients and methods</h4>Seventy-two patients who relapsed after immediate ... Read more >>

Pediatr Blood Cancer (Pediatric blood & cancer)
[2007, 48(5):493-499]

Cited: 42 times

View full text PDF listing >>



Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.

Monika L Metzger, Clinton F Stewart, Burgess B Freeman, Catherine A Billups, Fredric A Hoffer, Jianrong Wu, Max J Coppes, Ronald Grant, Murali Chintagumpala, Elizabeth A Mullen, Carlos Alvarado, Najat C Daw, Jeffrey S Dome,

<h4>Purpose</h4>A phase II study was conducted to evaluate the activity and safety of topotecan in pediatric patients with recurrent Wilms' tumor.<h4>Patients and methods</h4>Patients with favorable histology Wilms' tumor (FHWT) and recurrence after at least one salvage chemotherapy regimen or with anaplastic histology Wilms' tumor (AHWT) in first or subsequent recurrence ... Read more >>

J Clin Oncol (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2007, 25(21):3130-3136]

Cited: 29 times

View full text PDF listing >>



Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

Jeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, Norman E Breslow, John A Kalapurakal, Michael L Ritchey, Paul E Grundy, Marcio Malogolowkin, J Bruce Beckwith, Robert C Shamberger, Gerald M Haase, Max J Coppes, Peter Coccia, Morris Kletzel, Robert M Weetman, Milton Donaldson, Roger M Macklis, Daniel M Green,

<h4>Purpose</h4>An objective of the fifth National Wilms' Tumor Study (NWTS-5) was to evaluate the efficacy of treatment regimens for anaplastic histology Wilms' tumor (AH).<h4>Patients and methods</h4>Prospective single-arm studies were conducted. Patients with stage I AH were treated with vincristine and dactinomycin for 18 weeks. Patients with stages II to IV ... Read more >>

J Clin Oncol (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2006, 24(15):2352-2358]

Cited: 119 times

View full text PDF listing >>



Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.

Paul E Grundy, Norman E Breslow, Sierra Li, Elizabeth Perlman, J Bruce Beckwith, Michael L Ritchey, Robert C Shamberger, Gerald M Haase, Giulio J D'Angio, Milton Donaldson, Max J Coppes, Marcio Malogolowkin, Patricia Shearer, Patrick R M Thomas, Roger Macklis, Gail Tomlinson, Vicki Huff, Daniel M Green, ,

<h4>Purpose</h4>To determine if tumor-specific loss of heterozygosity (LOH) for chromosomes 1p or 16q is associated with a poorer prognosis for children with favorable-histology (FH) Wilms tumor entered on the fifth National Wilms Tumor Study (NWTS-5).<h4>Patients and methods</h4>Between August 1995 and June 2002, 2,021 previously untreated children with FH or anaplastic ... Read more >>

J Clin Oncol (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
[2005, 23(29):7312-7321]

Cited: 182 times

View full text PDF listing >>



Management of Wilms' tumour: current practice and future goals.

John A Kalapurakal, Jeffrey S Dome, Elizabeth J Perlman, Marcio Malogolowkin, Gerald M Haase, Paul Grundy, Max J Coppes,

Most patients with Wilms' tumour in Europe and North America can be cured with treatment and subsequently lead a normal adulthood. However, for some, therapy as applied today results in long-term side-effects and creates a substantial burden on quality of life. Therefore, investigators involved in the management of patients with ... Read more >>

Lancet Oncol (The Lancet. Oncology)
[2004, 5(1):37-46]

Cited: 91 times

View full text PDF listing >>



Advertisement


Disclaimer

1.0873 s